General Information of Drug (ID: DM7PGOJ)

Drug Name
GSK2556286
Synonyms
GSK2556286; UNII-J9U8H9VQV0; GSK-286; J9U8H9VQV0; GSK-2556286; 1210456-20-4; GSK286; 6-((4-(2,3-Dimethylphenoxy)-1-piperidinyl)methyl)-2,4(1H,3H)-pyrimidinedione; 2,4(1H,3H)-Pyrimidinedione, 6-((4-(2,3-dimethylphenoxy)-1-piperidinyl)methyl)-; 6-[[4-(2,3-dimethylphenoxy)piperidin-1-yl]methyl]-1H-pyrimidine-2,4-dione; CHEMBL4650308; SCHEMBL19380190; EX-A6180; MS-24944; HY-147017; CS-0514179; Z644646478
Indication
Disease Entry ICD 11 Status REF
Tuberculosis 1B10-1B14 Phase 1 [1]
Drug Type
Small molecule
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C18H23N3O3
Canonical SMILES
CC1=C(C(=CC=C1)OC2CCN(CC2)CC3=CC(=O)NC(=O)N3)C
InChI
InChI=1S/C18H23N3O3/c1-12-4-3-5-16(13(12)2)24-15-6-8-21(9-7-15)11-14-10-17(22)20-18(23)19-14/h3-5,10,15H,6-9,11H2,1-2H3,(H2,19,20,22,23)
InChIKey
AZOFJHATIPDIER-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
45833762
TTD ID
D07XUC

References

1 ClinicalTrials.gov (NCT04472897) A Randomised, Double Blind (Sponsor Unblinded), Placebo-controlled, First Time in Human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Oral Doses and the Food Effect of GSK2556286 in Healthy Adult Participants. U.S.National Institutes of Health.